Patient Newsletter | April 2025

If you’ve been diagnosed with early-stage prostate cancer, you’ll want to know about a new treatment option that is:

• Precise
• Minimizes damage to surrounding tissues
• Has lower rates of sexual, urinary, and gastrointestinal side effects.

LDR Brachytherapy with Palladium-103 involves inserting tiny radioactive seeds (about the size of a sesame seed) into the prostate gland. The seeds emit a continuous low level of radiation over several weeks. They destroy cancer cells without harming nearby tissue.

The 30–60-minute procedure can be combined with other therapies for men with intermediate or high-risk prostate cancer. LDR Brachytherapy is now available at our Town Center Ambulatory Surgery Center in collaboration with Western Radiation Oncology physicians.

It was just over a year ago that we celebrated the opening of our IR Center. Now, we’re already celebrating a significant milestone: 1,000 prostate artery embolizations (PAEs) have been performed there! PAE is an incision-free treatment option for men suffering from benign prostatic hyperplasia (BPH), especially those with very large prostates. PAE’s low complication rate and high success rate have made it a popular option for men with BPH.

Learn more about the PAE procedure by watching an online webinar on April 23 at 7:00 p.m. hosted by Dr. John Fallucca. It’s free and open to MIU patients, family, and friends. Register here.

Read about Joe’s experience with PAE. He explains how rushing to the bathroom up to 20 times a day while at work and waking five times a night to urinate are now a thing of the past.

If you need a procedure that doesn’t require an overnight stay, our two Ambulatory Surgery Centers (ASCs) in Troy and Utica (recently opened) may be an ideal option compared to the hospital. These two centers offer a huge benefit if you don’t want to deal with the complexity and hassle of navigating a large hospital.

Procedures for kidney stones, BPH, OAB, and even cancer treatments are now available at these two ASCs. You’ll find:

• Easy parking
• Quick check-in
• More personalized care
• Usually a lower cost

Town Center ASC is the Top Choice in Michigan!

We’re pleased to announce that Town Center ASC, located in Troy, has been recognized as one of the top urology ambulatory surgery centers (ASCs) for 2025 by U.S. News & World Report. Of the 708 ASCs evaluated throughout the U.S., our Troy ASC was included among the nation’s 63 “Best Ambulatory Surgery Centers” and was the only urology ASC in Michigan to receive this prestigious recognition.

Read the Press Release

We know your sexual wellness is sometimes overlooked, yet we want to empower you to enjoy your full sexual self. To make your sexual wellness services more within reach, REDEEM is now accepting the CareCredit healthcare credit card. The card allows you to pay for your treatment in monthly installments that fit your budget. Learn more about CareCredit and apply for the card.

Discover the range of sexual wellness services offered at REDEEM.

April 11 was National Pet Day. To celebrate, we invited our providers to snap a selfie with their pets. They’re lovable (the pets we mean, but our providers are adorable, too!). Here’s to all the pets who bring so much joy to our lives!

As the largest and most well-established urology practice in Southeast Michigan, MIU has been designated as a clinical trial site to assess the safety and effectiveness of an investigational combination immunotherapy designed to activate the immune system and eliminate prostate cancer cells throughout the body.

The LEGION-100 Trial is for men with metastatic castration-resistant prostate cancer. If you have prostate cancer that has spread beyond the prostate, and you’re already taking daily prostate cancer medications for your condition, you may be eligible for this investigational study.

Ask your doctor if the LEGION-100 Trial is right for you.